Given the data and tweets, could you project whether the closing price of $agn will grow or shrink at 2017-03-23? Please specify either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-03-09,0.1,0.6,-0.6,0.3,0.3,0.5,1.3,1.7,2.0,1.0,-0.8
2017-03-10,-0.3,0.5,-1.0,0.4,0.4,-0.3,0.8,1.2,1.5,0.8,-0.8
2017-03-13,0.3,0.5,-0.2,-0.2,-0.2,-0.2,0.7,1.2,1.6,1.2,-0.2
2017-03-14,0.0,0.7,-0.4,-0.5,-0.5,0.3,1.0,1.5,2.0,1.8,0.7
2017-03-15,-0.5,0.2,-1.4,0.5,0.5,-0.1,0.3,0.9,1.3,1.4,0.5
2017-03-16,0.8,0.8,-0.3,-0.5,-0.5,0.4,0.6,1.2,1.6,1.9,1.1
2017-03-17,0.6,1.3,-0.1,-0.9,-0.9,0.9,1.1,1.9,2.3,2.7,2.1
2017-03-20,0.4,0.4,-0.2,-0.2,-0.2,0.8,1.1,1.8,2.3,2.7,2.4
2017-03-21,1.1,1.7,-0.1,-1.0,-1.0,1.4,1.9,2.5,3.1,3.5,3.5
2017-03-22,0.1,1.0,-0.3,-0.2,-0.2,1.1,1.9,2.5,3.1,3.6,3.8

2017-03-09: AT_USER AT_USER they get a commercial partner in due course. buyout possible (but not by $agn).|AT_USER i think $agn is undervalued; what about u?|AT_USER since advent of(relatively)long-lasting derma
2017-03-10: why valeant $vrx $agn $myl $mrk $jnj $snap $twtr $fb $aapl $iep $gild $tst $amgn $ko $pep $tsla $ge $gm $ibm $baba¡­ |rt AT_USER valeant railroading short's bankrupctythesis $vrx $agn $myl $mrk $ko $p
2017-03-11: hi hope ya'll got a chance to enjoy this. perfect end of line. shot down? $vrx $agn $twtr $aapl $ko $pep $tst $tsla |$agn - buy signal at 241.49 on mar 10, 17 by  trading robot#stockstowatch #stockmar
2017-03-12: rt AT_USER 713% valeant upside with net income rec $agn $iep $myl $brk $pep $tsla $amzn $msft $googl $jnj $gild $exel $shak $cake $pyp¡­|rt AT_USER your failure to bring an $agn case against pershing 
2017-03-13: rt AT_USER david tepper to appear on cnbc at 7:30am et on wed. watch if he makes any comment on his new buys  $teva $myl $mu $aal  &amp; hi¡­|rt AT_USER huge upside for valeant! $vrx $agn $myl $mrk $j
2017-03-14: common joins #allergan's campaign against vision loss. read more:  $agn|common joins #allergan's campaign against vision loss. read more:  $agn|$agn:na look at aegon n.v. preferred for a 6.5% yield #a
2017-03-15: #allergan cramer on how investors should maneuver amid ceo buybacks. read more:  $agn|#allergan cramer on how investors should maneuver amid ceo buybacks. read more:  $agn|AT_USER AT_USER wait till th
2017-03-16: #allergan cramer on how investors should maneuver amid ceo buybacks. read more:  $agn|#allergan cramer on how investors should maneuver amid ceo buybacks. read more:  $agn|rt AT_USER phenomenal stock 
2017-03-17: AT_USER buyout is a definitely. look at $tbra buyout from $agn, $cerc, $innl $exel|AT_USER added to $regn today.  $agn got my eye also.  consolidating nicely back to the moving averages.|AT_USER as pa
2017-03-18: AT_USER would be sweet if $agn comes in and sweeps up $auph at 1.7b +++|hoping $auph partners voclo in ln for c.$1.2bn, keeping dry eye for itself. $agn's restasis sells ~$1.5bn/yr. voclo the superior
2017-03-19: projected weekly ranges in select stocks (mar 20-24): $aapl $agn $amzn $bac $fb $goog $gild $nflx $nvda $tsla $spy¡­ |rt AT_USER first look at projected weekly ranges in select stocks: $aapl $agn $amz
2017-03-20: $edit, $agn, $edit editas get a vetr upgrade to strong buy - |rt AT_USER lilly takes a stab at pricing transparency, but is it enough of the right data?  #pharma $lly $mrk $j¡­|#allergan brief-juv&amp
2017-03-21: assuming the market doesn't completely fall apart, $agn, looks a lot like a cup and handle pattern. just had a good¡­ |AT_USER AT_USER $hlf $agn you can't make this shit up. |rt AT_USER lilly takes a 
2017-03-22: rt AT_USER $ibb $xbi $celg $agn $amgn $regn $gild can't stress the importance of this video enough! $study |$ibb $xbi $celg $agn $amgn $regn $gild can't stress the importance of this video enough! $st
Answer:
Given the data and tweets, could you project whether the closing price of $agn will grow or shrink at 2017-03-23? Please specify either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-03-09,0.1,0.6,-0.6,0.3,0.3,0.5,1.3,1.7,2.0,1.0,-0.8
2017-03-10,-0.3,0.5,-1.0,0.4,0.4,-0.3,0.8,1.2,1.5,0.8,-0.8
2017-03-13,0.3,0.5,-0.2,-0.2,-0.2,-0.2,0.7,1.2,1.6,1.2,-0.2
2017-03-14,0.0,0.7,-0.4,-0.5,-0.5,0.3,1.0,1.5,2.0,1.8,0.7
2017-03-15,-0.5,0.2,-1.4,0.5,0.5,-0.1,0.3,0.9,1.3,1.4,0.5
2017-03-16,0.8,0.8,-0.3,-0.5,-0.5,0.4,0.6,1.2,1.6,1.9,1.1
2017-03-17,0.6,1.3,-0.1,-0.9,-0.9,0.9,1.1,1.9,2.3,2.7,2.1
2017-03-20,0.4,0.4,-0.2,-0.2,-0.2,0.8,1.1,1.8,2.3,2.7,2.4
2017-03-21,1.1,1.7,-0.1,-1.0,-1.0,1.4,1.9,2.5,3.1,3.5,3.5
2017-03-22,0.1,1.0,-0.3,-0.2,-0.2,1.1,1.9,2.5,3.1,3.6,3.8

2017-03-09: AT_USER AT_USER they get a commercial partner in due course. buyout possible (but not by $agn).|AT_USER i think $agn is undervalued; what about u?|AT_USER since advent of(relatively)long-lasting derma
2017-03-10: why valeant $vrx $agn $myl $mrk $jnj $snap $twtr $fb $aapl $iep $gild $tst $amgn $ko $pep $tsla $ge $gm $ibm $baba¡­ |rt AT_USER valeant railroading short's bankrupctythesis $vrx $agn $myl $mrk $ko $p
2017-03-11: hi hope ya'll got a chance to enjoy this. perfect end of line. shot down? $vrx $agn $twtr $aapl $ko $pep $tst $tsla |$agn - buy signal at 241.49 on mar 10, 17 by  trading robot#stockstowatch #stockmar
2017-03-12: rt AT_USER 713% valeant upside with net income rec $agn $iep $myl $brk $pep $tsla $amzn $msft $googl $jnj $gild $exel $shak $cake $pyp¡­|rt AT_USER your failure to bring an $agn case against pershing 
2017-03-13: rt AT_USER david tepper to appear on cnbc at 7:30am et on wed. watch if he makes any comment on his new buys  $teva $myl $mu $aal  &amp; hi¡­|rt AT_USER huge upside for valeant! $vrx $agn $myl $mrk $j
2017-03-14: common joins #allergan's campaign against vision loss. read more:  $agn|common joins #allergan's campaign against vision loss. read more:  $agn|$agn:na look at aegon n.v. preferred for a 6.5% yield #a
2017-03-15: #allergan cramer on how investors should maneuver amid ceo buybacks. read more:  $agn|#allergan cramer on how investors should maneuver amid ceo buybacks. read more:  $agn|AT_USER AT_USER wait till th
2017-03-16: #allergan cramer on how investors should maneuver amid ceo buybacks. read more:  $agn|#allergan cramer on how investors should maneuver amid ceo buybacks. read more:  $agn|rt AT_USER phenomenal stock 
2017-03-17: AT_USER buyout is a definitely. look at $tbra buyout from $agn, $cerc, $innl $exel|AT_USER added to $regn today.  $agn got my eye also.  consolidating nicely back to the moving averages.|AT_USER as pa
2017-03-18: AT_USER would be sweet if $agn comes in and sweeps up $auph at 1.7b +++|hoping $auph partners voclo in ln for c.$1.2bn, keeping dry eye for itself. $agn's restasis sells ~$1.5bn/yr. voclo the superior
2017-03-19: projected weekly ranges in select stocks (mar 20-24): $aapl $agn $amzn $bac $fb $goog $gild $nflx $nvda $tsla $spy¡­ |rt AT_USER first look at projected weekly ranges in select stocks: $aapl $agn $amz
2017-03-20: $edit, $agn, $edit editas get a vetr upgrade to strong buy - |rt AT_USER lilly takes a stab at pricing transparency, but is it enough of the right data?  #pharma $lly $mrk $j¡­|#allergan brief-juv&amp
2017-03-21: assuming the market doesn't completely fall apart, $agn, looks a lot like a cup and handle pattern. just had a good¡­ |AT_USER AT_USER $hlf $agn you can't make this shit up. |rt AT_USER lilly takes a 
2017-03-22: rt AT_USER $ibb $xbi $celg $agn $amgn $regn $gild can't stress the importance of this video enough! $study |$ibb $xbi $celg $agn $amgn $regn $gild can't stress the importance of this video enough! $st
Answer:+Rise